NCT05279937View on ClinicalTrials.gov

The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ehlers-Danlos SyndromeLow Back PainSacroiliac Instability
Interventions
DRUG

Dextrose 50% Intravenous Solution

5mL of 50% Dextrose + 5mL of 1% Lidocaine (Prolotherapy).

DRUG

Lidocaine 1% Injectable Solution

10mL of 1% Lidocaine (Control)

Trial Locations (1)

70118

Tulane Hospital and Clinics, New Orleans

All Listed Sponsors
lead

Tulane University

OTHER